FDA approval expands access to artificial heart valve for inoperable patients

The U.S. Food and Drug Administration has approved revised labeling for the Sapien Transcatheter Heart Valve (THV), making the device available to an expanded group of patients who have inoperable aortic valve stenosis, a disease of the heart valves that causes narrowing of the aortic valve, restricting blood flow from the heart. People with severe aortic valve stenosis must have a heart valve replacement to restore normal blood flow...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/uFm473-CM6Q/266678.php

sport medical sport news news